チロシンキナーゼ阻害剤の世界市場レポート 2023年以下を含む1) タイプ別1)タイプ別:BCR-ABLチロシンキナーゼ阻害剤;上皮成長因子受容体(EGFR)チロシンキナーゼ阻害剤;血管内皮成長因子受容体(VEGFR)チロシンキナーゼ阻害剤2)流通チャネル別:病院薬局;独立薬局;オンライン薬局3)用途別:病院薬局;独立薬局;オンライン薬局病院薬局;独立薬局;オンライン薬局3) 用途別慢性骨髄性白血病(CML);肺がん;乳がん;腎細胞がんCovering:ファイザー;ジョンソン・エンド・ジョンソン;エフ・ホフマン・ラ・ロシュ;アッヴィ;バイエルTyrosine Kinase Inhibitors Global Market Report 2023Including: 1) By Type: BCR-ABL Tyrosine Kinase Inhibitor; Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors; Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitors2) By Distribution Channel: Hospital Pharmacy; Independent Pharmacies; Online Pharmacies3) By Application: Chronic Myeloid Leukemia (CML); Lung Cancer; Breast Cancer; Renal Cell CancerCovering: Pfizer Inc.; Johnson And Johnson Private Limited.; F. Hoffmann-La Roche AG; AbbVie Inc.; Bayer AG The Business Research Companyのチロシンキナーゼ阻害剤の世界市場レポート2023は、戦略担当者、マーケティング担当者、経営幹部が市場を評価するために必要な重要情報を提供します。 このレポートは力強い成... もっと見る
サマリーThe Business Research Companyのチロシンキナーゼ阻害剤の世界市場レポート2023は、戦略担当者、マーケティング担当者、経営幹部が市場を評価するために必要な重要情報を提供します。このレポートは力強い成長を遂げているチロシンキナーゼ阻害剤市場に焦点を当てています。今後10年間およびそれ以降の市場を形成するトレンドのガイドを提供します。 購入の理由 - 50以上の地域をカバーするこの市場に関する最も包括的なレポートにより、真のグローバルな視点を得ることができます。 - 市場がCOVID-19の影響をどのように受けてきたか、またウイルスの影響が和らぐにつれて市場がどのように対応しているかを理解する。 - ロシア・ウクライナ戦争が農業、エネルギー、鉱物資源供給に与える影響と、市場への直接的・間接的影響を評価する。 - 世界的な高インフレが市場成長に与える影響を測定する。 - 現地のデータと分析に基づき、地域戦略と国別戦略を策定する。 - 投資の対象となる成長セグメントを特定する。 - 予測データと市場を形成する原動力とトレンドを活用し、競合他社を凌駕する。 - 最新の市場シェアに基づいて顧客を理解する。 - 主要な競合他社に対する業績のベンチマーク - 信頼性の高い高品質のデータと分析により、社内外でのプレゼンテーションをサポートするのに適しています。 - レポートは最新データに更新され、データ抽出と分析が簡単にできるExcelデータシートとともに、ご注文から3~5営業日以内にお届けします。 - レポートの全データは、エクセルのダッシュボード形式でも納品されます。 説明 チロシンキナーゼ阻害剤の市場が最も大きく、急成長しているのはどこか?経済全体、人口動態、他の類似市場との関連は?今後の市場を形成する力は何か?ビジネスリサーチ社のチロシンキナーゼ阻害剤世界市場レポートでは、これらすべての疑問やその他多くの疑問にお答えします。 本レポートでは、市場の特徴、規模と成長、セグメンテーション、地域別および国別内訳、競合環境、市場シェア、トレンド、戦略などを網羅しています。地域別に市場の過去および予測市場成長を追跡します。 調査範囲 対象市場:1) タイプ別BCR-ABLチロシンキナーゼ阻害剤;上皮成長因子受容体(EGFR)チロシンキナーゼ阻害剤;血管内皮成長因子受容体(VEGFR)チロシンキナーゼ阻害剤;その他のタイプ 2) 販売チャネル別病院薬局;独立薬局;オンライン薬局 3) 用途別用途別:慢性骨髄性白血病(CML)、肺がん、乳がん、腎細胞がん、その他 言及された企業ファイザー株式会社、ジョンソン・エンド・ジョンソン株式会社、エフ・ホフマン・ラ・ロシュ株式会社、アッヴィ株式会社、バイエル株式会社 国名オーストラリア、ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、ロシア、韓国、英国、米国、カナダ、イタリア、スペイン 地域アジア太平洋; 西ヨーロッパ; 東ヨーロッパ; 北アメリカ; 南アメリカ; 中東; アフリカ 時系列:過去5年間および過去10年間の予測。 データ市場規模と成長率の関連市場に対する比率、GDP比率、一人当たり支出、 データ区分:国別・地域別の過去データと予測データ、競合他社の市場シェア、市場セグメント。 ソーシングと参照:本レポート中のデータおよび分析は、エンドノートを使用しています。 納品形式PDF、Word、Excel データダッシュボード。 目次1. Executive Summary2. Tyrosine Kinase Inhibitors Market Characteristics 3. Tyrosine Kinase Inhibitors Market Trends And Strategies 4. Tyrosine Kinase Inhibitors Market - Macro Economic Scenario 4.1. Impact Of High Inflation On Online Therapy Services Market 4.2. Ukraine-Russia War Impact On Online Therapy Services Market 4.3. COVID-19 Impact On Online Therapy Services Market 5.1. Global Tyrosine Kinase Inhibitors Historic Market Size and Growth, 2017 - 2022, Value ($ Billion) 5.2. Global Tyrosine Kinase Inhibitors Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion) 5.3. Global Tyrosine Kinase Inhibitors Market Drivers and Restraints 5.3.1. Drivers Of The Market 5.3.2. Restraints Of The Market 6. Tyrosine Kinase Inhibitors Market Segmentation 6.1. Global Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion BCR-ABL Tyrosine Kinase Inhibitor Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitors Other Types 6.2. Global Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Hospital Pharmacy Independent Pharmacies Online Pharmacies 6.3. Global Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Chronic Myeloid Leukemia (CML) Lung Cancer Breast Cancer Renal Cell Cancer Other Applications 7. Tyrosine Kinase Inhibitors Market Regional And Country Analysis 7.1. Global Tyrosine Kinase Inhibitors Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 7.2. Global Tyrosine Kinase Inhibitors Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8. Asia-Pacific Tyrosine Kinase Inhibitors Market 8.1. Asia-Pacific Tyrosine Kinase Inhibitors Market Overview Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies 8.2. Asia-Pacific Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.3. Asia-Pacific Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.4. Asia-Pacific Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 9. China Tyrosine Kinase Inhibitors Market 9.1. China Tyrosine Kinase Inhibitors Market Overview 9.2. China Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.3. China Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.4. China Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 10. India Tyrosine Kinase Inhibitors Market 10.1. India Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.2. India Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.3. India Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11. Japan Tyrosine Kinase Inhibitors Market 11.1. Japan Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.2. Japan Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.3. Japan Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12. Australia Tyrosine Kinase Inhibitors Market 12.1. Australia Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.2. Australia Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.3. Australia Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13. Indonesia Tyrosine Kinase Inhibitors Market 13.1. Indonesia Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.2. Indonesia Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.3. Indonesia Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14. South Korea Tyrosine Kinase Inhibitors Market 14.1. South Korea Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.2. South Korea Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.3. South Korea Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15. Western Europe Tyrosine Kinase Inhibitors Market 15.1. Western Europe Tyrosine Kinase Inhibitors Market Overview 15.2. Western Europe Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.3. Western Europe Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.4. Western Europe Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16. UK Tyrosine Kinase Inhibitors Market 16.1. UK Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.2. UK Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.3. UK Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17. Germany Tyrosine Kinase Inhibitors Market 17.1. Germany Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.2. Germany Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.3. Germany Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18. France Tyrosine Kinase Inhibitors Market 18.1. France Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.2. France Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.3. France Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19. Italy Tyrosine Kinase Inhibitors Market 19.1. Italy Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.2. Italy Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.3. Italy Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20. Spain Tyrosine Kinase Inhibitors Market 20.1. Spain Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.2. Spain Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.3. Spain Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21. Eastern Europe Tyrosine Kinase Inhibitors Market 21.1. Eastern Europe Tyrosine Kinase Inhibitors Market Overview 21.2. Eastern Europe Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.3. Eastern Europe Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.4. Eastern Europe Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22. Russia Tyrosine Kinase Inhibitors Market 22.1. Russia Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.2. Russia Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.3. Russia Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23. North America Tyrosine Kinase Inhibitors Market 23.1. North America Tyrosine Kinase Inhibitors Market Overview 23.2. North America Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.3. North America Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.4. North America Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24. USA Tyrosine Kinase Inhibitors Market 24.1. USA Tyrosine Kinase Inhibitors Market Overview 24.2. USA Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.3. USA Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.4. USA Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25. Canada Tyrosine Kinase Inhibitors Market 25.1. Canada Tyrosine Kinase Inhibitors Market Overview 25.2. Canada Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.3. Canada Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.4. Canada Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26. South America Tyrosine Kinase Inhibitors Market 26.1. South America Tyrosine Kinase Inhibitors Market Overview 26.2. South America Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.3. South America Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.4. South America Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27. Brazil Tyrosine Kinase Inhibitors Market 27.1. Brazil Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.2. Brazil Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.3. Brazil Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28. Middle East Tyrosine Kinase Inhibitors Market 28.1. Middle East Tyrosine Kinase Inhibitors Market Overview 28.2. Middle East Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.3. Middle East Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.4. Middle East Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29. Africa Tyrosine Kinase Inhibitors Market 29.1. Africa Tyrosine Kinase Inhibitors Market Overview 29.2. Africa Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.3. Africa Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.4. Africa Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 30. Tyrosine Kinase Inhibitors Market Competitive Landscape And Company Profiles 30.1. Tyrosine Kinase Inhibitors Market Competitive Landscape 30.2. Tyrosine Kinase Inhibitors Market Company Profiles 30.2.1. Pfizer Inc. 30.2.1.1. Overview 30.2.1.2. Products and Services 30.2.1.3. Strategy 30.2.1.4. Financial Performance 30.2.2. Johnson And Johnson Private Limited. 30.2.2.1. Overview 30.2.2.2. Products and Services 30.2.2.3. Strategy 30.2.2.4. Financial Performance 30.2.3. F. Hoffmann-La Roche AG 30.2.3.1. Overview 30.2.3.2. Products and Services 30.2.3.3. Strategy 30.2.3.4. Financial Performance 30.2.4. AbbVie Inc. 30.2.4.1. Overview 30.2.4.2. Products and Services 30.2.4.3. Strategy 30.2.4.4. Financial Performance 30.2.5. Bayer AG 30.2.5.1. Overview 30.2.5.2. Products and Services 30.2.5.3. Strategy 30.2.5.4. Financial Performance 31. Tyrosine Kinase Inhibitors Market Other Major And Innovative Companies 31.1. Novartis AG 31.2. Sanofi S.A. 31.3. Bristol-Myers Squibb Company 31.4. AstraZeneca Plc. 31.5. GlaxoSmithKline plc 31.6. Eli Lilly and Company 31.7. Amgen Inc. 31.8. Boehringer Ingelheim International GmbH 31.9. Teva Pharmaceutical Industries Ltd. 31.10. Regeneron Pharmaceuticals Inc. 31.11. Astellas Pharma Inc. 31.12. Eisai Co. Ltd 31.13. Incyte Corporation 31.14. Dr. Reddy's Laboratories Ltd. 31.15. Exelixis Inc. 32. Global Tyrosine Kinase Inhibitors Market Competitive Benchmarking 33. Global Tyrosine Kinase Inhibitors Market Competitive Dashboard 34. Key Mergers And Acquisitions In The Tyrosine Kinase Inhibitors Market 35. Tyrosine Kinase Inhibitors Market Future Outlook and Potential Analysis 35.1 Tyrosine Kinase Inhibitors Market In 2027 - Countries Offering Most New Opportunities 35.2 Tyrosine Kinase Inhibitors Market In 2027 - Segments Offering Most New Opportunities 35.3 Tyrosine Kinase Inhibitors Market In 2027 - Growth Strategies 35.3.1 Market Trend Based Strategies 35.3.2 Competitor Strategies 36. Appendix 36.1. Abbreviations 36.2. Currencies 36.3. Historic And Forecast Inflation Rates 36.4. Research Inquiries 36.5. The Business Research Company 36.6. Copyright And Disclaimer
SummaryTyrosine Kinase Inhibitors Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. Table of Contents1. Executive Summary2. Tyrosine Kinase Inhibitors Market Characteristics 3. Tyrosine Kinase Inhibitors Market Trends And Strategies 4. Tyrosine Kinase Inhibitors Market - Macro Economic Scenario 4.1. Impact Of High Inflation On Online Therapy Services Market 4.2. Ukraine-Russia War Impact On Online Therapy Services Market 4.3. COVID-19 Impact On Online Therapy Services Market 5.1. Global Tyrosine Kinase Inhibitors Historic Market Size and Growth, 2017 - 2022, Value ($ Billion) 5.2. Global Tyrosine Kinase Inhibitors Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion) 5.3. Global Tyrosine Kinase Inhibitors Market Drivers and Restraints 5.3.1. Drivers Of The Market 5.3.2. Restraints Of The Market 6. Tyrosine Kinase Inhibitors Market Segmentation 6.1. Global Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion BCR-ABL Tyrosine Kinase Inhibitor Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitors Other Types 6.2. Global Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Hospital Pharmacy Independent Pharmacies Online Pharmacies 6.3. Global Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Chronic Myeloid Leukemia (CML) Lung Cancer Breast Cancer Renal Cell Cancer Other Applications 7. Tyrosine Kinase Inhibitors Market Regional And Country Analysis 7.1. Global Tyrosine Kinase Inhibitors Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 7.2. Global Tyrosine Kinase Inhibitors Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8. Asia-Pacific Tyrosine Kinase Inhibitors Market 8.1. Asia-Pacific Tyrosine Kinase Inhibitors Market Overview Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies 8.2. Asia-Pacific Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.3. Asia-Pacific Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.4. Asia-Pacific Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 9. China Tyrosine Kinase Inhibitors Market 9.1. China Tyrosine Kinase Inhibitors Market Overview 9.2. China Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.3. China Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.4. China Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 10. India Tyrosine Kinase Inhibitors Market 10.1. India Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.2. India Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.3. India Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11. Japan Tyrosine Kinase Inhibitors Market 11.1. Japan Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.2. Japan Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.3. Japan Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12. Australia Tyrosine Kinase Inhibitors Market 12.1. Australia Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.2. Australia Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.3. Australia Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13. Indonesia Tyrosine Kinase Inhibitors Market 13.1. Indonesia Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.2. Indonesia Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.3. Indonesia Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14. South Korea Tyrosine Kinase Inhibitors Market 14.1. South Korea Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.2. South Korea Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.3. South Korea Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15. Western Europe Tyrosine Kinase Inhibitors Market 15.1. Western Europe Tyrosine Kinase Inhibitors Market Overview 15.2. Western Europe Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.3. Western Europe Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.4. Western Europe Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16. UK Tyrosine Kinase Inhibitors Market 16.1. UK Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.2. UK Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.3. UK Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17. Germany Tyrosine Kinase Inhibitors Market 17.1. Germany Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.2. Germany Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.3. Germany Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18. France Tyrosine Kinase Inhibitors Market 18.1. France Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.2. France Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.3. France Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19. Italy Tyrosine Kinase Inhibitors Market 19.1. Italy Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.2. Italy Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.3. Italy Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20. Spain Tyrosine Kinase Inhibitors Market 20.1. Spain Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.2. Spain Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.3. Spain Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21. Eastern Europe Tyrosine Kinase Inhibitors Market 21.1. Eastern Europe Tyrosine Kinase Inhibitors Market Overview 21.2. Eastern Europe Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.3. Eastern Europe Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.4. Eastern Europe Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22. Russia Tyrosine Kinase Inhibitors Market 22.1. Russia Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.2. Russia Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.3. Russia Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23. North America Tyrosine Kinase Inhibitors Market 23.1. North America Tyrosine Kinase Inhibitors Market Overview 23.2. North America Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.3. North America Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.4. North America Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24. USA Tyrosine Kinase Inhibitors Market 24.1. USA Tyrosine Kinase Inhibitors Market Overview 24.2. USA Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.3. USA Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.4. USA Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25. Canada Tyrosine Kinase Inhibitors Market 25.1. Canada Tyrosine Kinase Inhibitors Market Overview 25.2. Canada Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.3. Canada Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.4. Canada Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26. South America Tyrosine Kinase Inhibitors Market 26.1. South America Tyrosine Kinase Inhibitors Market Overview 26.2. South America Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.3. South America Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.4. South America Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27. Brazil Tyrosine Kinase Inhibitors Market 27.1. Brazil Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.2. Brazil Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.3. Brazil Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28. Middle East Tyrosine Kinase Inhibitors Market 28.1. Middle East Tyrosine Kinase Inhibitors Market Overview 28.2. Middle East Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.3. Middle East Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.4. Middle East Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29. Africa Tyrosine Kinase Inhibitors Market 29.1. Africa Tyrosine Kinase Inhibitors Market Overview 29.2. Africa Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.3. Africa Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.4. Africa Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 30. Tyrosine Kinase Inhibitors Market Competitive Landscape And Company Profiles 30.1. Tyrosine Kinase Inhibitors Market Competitive Landscape 30.2. Tyrosine Kinase Inhibitors Market Company Profiles 30.2.1. Pfizer Inc. 30.2.1.1. Overview 30.2.1.2. Products and Services 30.2.1.3. Strategy 30.2.1.4. Financial Performance 30.2.2. Johnson And Johnson Private Limited. 30.2.2.1. Overview 30.2.2.2. Products and Services 30.2.2.3. Strategy 30.2.2.4. Financial Performance 30.2.3. F. Hoffmann-La Roche AG 30.2.3.1. Overview 30.2.3.2. Products and Services 30.2.3.3. Strategy 30.2.3.4. Financial Performance 30.2.4. AbbVie Inc. 30.2.4.1. Overview 30.2.4.2. Products and Services 30.2.4.3. Strategy 30.2.4.4. Financial Performance 30.2.5. Bayer AG 30.2.5.1. Overview 30.2.5.2. Products and Services 30.2.5.3. Strategy 30.2.5.4. Financial Performance 31. Tyrosine Kinase Inhibitors Market Other Major And Innovative Companies 31.1. Novartis AG 31.2. Sanofi S.A. 31.3. Bristol-Myers Squibb Company 31.4. AstraZeneca Plc. 31.5. GlaxoSmithKline plc 31.6. Eli Lilly and Company 31.7. Amgen Inc. 31.8. Boehringer Ingelheim International GmbH 31.9. Teva Pharmaceutical Industries Ltd. 31.10. Regeneron Pharmaceuticals Inc. 31.11. Astellas Pharma Inc. 31.12. Eisai Co. Ltd 31.13. Incyte Corporation 31.14. Dr. Reddy's Laboratories Ltd. 31.15. Exelixis Inc. 32. Global Tyrosine Kinase Inhibitors Market Competitive Benchmarking 33. Global Tyrosine Kinase Inhibitors Market Competitive Dashboard 34. Key Mergers And Acquisitions In The Tyrosine Kinase Inhibitors Market 35. Tyrosine Kinase Inhibitors Market Future Outlook and Potential Analysis 35.1 Tyrosine Kinase Inhibitors Market In 2027 - Countries Offering Most New Opportunities 35.2 Tyrosine Kinase Inhibitors Market In 2027 - Segments Offering Most New Opportunities 35.3 Tyrosine Kinase Inhibitors Market In 2027 - Growth Strategies 35.3.1 Market Trend Based Strategies 35.3.2 Competitor Strategies 36. Appendix 36.1. Abbreviations 36.2. Currencies 36.3. Historic And Forecast Inflation Rates 36.4. Research Inquiries 36.5. The Business Research Company 36.6. Copyright And Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医薬)の最新刊レポート
The Business Research Company (TBRC)社の医薬分野での最新刊レポート
本レポートと同じKEY WORD(vascular)の最新刊レポート
よくあるご質問The Business Research Company (TBRC)社はどのような調査会社ですか?The Business Research Company (TBRC)はインドを主要拠点に世界の多様な市場を調査・予測し、調査レポートを積極的に出版しています。調査対象には技術、ライフサイエンス、重... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |